+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sustained Release Injectables Market by Application, Product Type, Polymer Type, Route Of Administration, End User - Global Forecast to 2030- Product Image
Sustained Release Injectables Market by Application, Product Type, Polymer Type, Route Of Administration, End User - Global Forecast to 2030- Product Image
Sale

Sustained Release Injectables Market by Application, Product Type, Polymer Type, Route Of Administration, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533434
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The sustained release injectables market is undergoing significant transformation as demand grows for therapies that deliver consistent, long-term results with fewer interventions. Senior decision-makers are seeking insights to navigate changing patient needs, technological advancements, and evolving global supply dynamics in this critical pharmaceutical segment.

Market Snapshot: Sustained Release Injectables Market

The Sustained Release Injectables Market grew from USD 2.29 billion in 2024 to USD 2.45 billion in 2025. It is expected to continue growing at a CAGR of 7.04%, reaching USD 3.45 billion by 2030. This trajectory reflects increased investment in advanced drug-delivery systems, expansion of biologics and specialty drugs, and a rise in chronic disease incidence globally.

Scope & Segmentation

  • Application Areas: Hormonal therapies (including diabetes and contraceptives), oncology (hematological malignancies and solid tumors such as breast and lung cancer), pain management, and vaccine platforms.
  • Product Types: Cartridges, implantable pumps for continuous infusion, pre-filled syringes for single-dose use, and unfilled vials for custom compounding.
  • Polymer Categories: Biodegradable (polycaprolactone, polylactic acid, polylactic-co-glycolic acid) and non-biodegradable (polyethylene, polysiloxanes) polymers that tailor degradation and release profiles.
  • Routes of Administration: Epidural, intramuscular, intravitreal, and subcutaneous injections address a spectrum of clinical requirements from pain relief to ophthalmic therapy.
  • End Users: Ambulatory surgical centers, clinics, home healthcare providers, and hospitals require different system integrations and workflows.
  • Regional Coverage: Americas (including United States, Canada, Brazil, Mexico, Argentina), EMEA (United Kingdom, Germany, France, major Middle Eastern and African economies, and additional European markets), and Asia-Pacific (China, India, Japan, Australia, and Southeast Asian countries).
  • Key Companies: Market participants include Johnson & Johnson, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, Sanofi S.A., GlaxoSmithKline plc, AbbVie Inc., Abbott Laboratories, Amgen Inc., and Baxter International Inc.

Key Takeaways for Stakeholders

  • Polymer innovation enhances tailored drug release, aligning formulation design with distinct therapeutic demands and supporting adoption of long-acting regimens.
  • Digital integration—such as connected platforms and smart infusion systems—expands real-time monitoring and patient engagement outside traditional hospital settings.
  • Regulatory frameworks are adapting to accommodate innovative drug-device combinations, particularly those targeting oncology and rare disease segments.
  • Supply chain resilience is a rising priority, with companies negotiating dual-source agreements and deepening ties with contract manufacturers for critical materials and fill-finish capabilities.
  • Regional investment patterns and healthcare infrastructure influence adoption rates and the extent of access, incentivizing tailored commercial approaches by geography.

Tariff Impact

Entering 2025, U.S. tariffs on essential pharmaceutical inputs—such as polymer resins and specialized siloxanes—have increased input costs for sustained release injectables. In response, manufacturers are optimizing procurement strategies, exploring domestic and alternative sources, and prioritizing cost-effective material selection to maintain supply continuity and margin integrity. Strategic partnerships and long-term contracts have become essential to mitigating volatility and promoting transparency across the value chain.

Methodology & Data Sources

This report uses primary interviews with executives, scientists, and regulatory advisors, alongside secondary research from peer-reviewed journals, patent filings, and company disclosures. Data triangulation validates findings, while continuous expert feedback ensures segmentation accuracy and reliability of qualitative and quantitative insights.

Sustained Release Injectables Market: Why This Report Matters

  • Enables strategic investment by delivering clear segmentation intelligence and emerging trend analysis across key therapeutic and regional domains.
  • Guides operational and procurement decisions in response to tariff changes and evolving regulatory landscapes, supporting sustained competitiveness and compliance.
  • Facilitates the development of innovative offerings by pinpointing unmet clinical needs and new partnership opportunities among leading market players.

Conclusion

The sustained release injectables market stands at a turning point defined by evolving therapies, novel delivery technologies, and adaptive supply strategies. This analysis equips senior leaders with actionable insights to advance organizational objectives and competitor differentiation for long-term growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Sustained Release Injectables Market, by Application
8.1. Introduction
8.2. Hormonal Therapies
8.3. Oncology
8.3.1. Hematological Malignancies
8.3.2. Solid Tumors
8.3.2.1. Breast Cancer
8.3.2.2. Lung Cancer
8.4. Pain Management
8.5. Vaccines
9. Sustained Release Injectables Market, by Product Type
9.1. Introduction
9.2. Cartridges
9.3. Implantable Pumps
9.4. Pre-Filled Syringes
9.5. Unfilled Vials
10. Sustained Release Injectables Market, by Polymer Type
10.1. Introduction
10.2. Biodegradable Polymers
10.2.1. PCL
10.2.2. PLA
10.2.3. PLGA
10.3. Non-Biodegradable Polymers
10.3.1. Polyethylene
10.3.2. Polysiloxanes
11. Sustained Release Injectables Market, by Route Of Administration
11.1. Introduction
11.2. Epidural
11.3. Intramuscular
11.4. Intravitreal
11.5. Subcutaneous
12. Sustained Release Injectables Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Clinics
12.4. Home Healthcare
12.5. Hospitals
13. Americas Sustained Release Injectables Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Sustained Release Injectables Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Sustained Release Injectables Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Novartis AG
16.3.3. Pfizer Inc.
16.3.4. F. Hoffmann-La Roche Ltd
16.3.5. Sanofi S.A.
16.3.6. GlaxoSmithKline plc
16.3.7. AbbVie Inc.
16.3.8. Abbott Laboratories
16.3.9. Amgen Inc.
16.3.10. Baxter International Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SUSTAINED RELEASE INJECTABLES MARKET MULTI-CURRENCY
FIGURE 2. SUSTAINED RELEASE INJECTABLES MARKET MULTI-LANGUAGE
FIGURE 3. SUSTAINED RELEASE INJECTABLES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SUSTAINED RELEASE INJECTABLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SUSTAINED RELEASE INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SUSTAINED RELEASE INJECTABLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY IMPLANTABLE PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY UNFILLED VIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PCL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PLGA, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYSILOXANES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY INTRAVITREAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 64. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 65. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 68. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 69. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. CANADA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 73. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. MEXICO SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 119. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 122. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 128. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 131. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 132. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 133. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. FRANCE SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 146. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 147. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 149. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 150. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 151. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. ITALY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 155. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 158. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 159. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 160. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. SPAIN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 191. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 194. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 195. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 196. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 197. DENMARK SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 209. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 210. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 212. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 213. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 214. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 215. QATAR SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 218. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 223. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. FINLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 245. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 248. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 249. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 250. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 251. EGYPT SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 254. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 257. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 258. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 259. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 260. TURKEY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 272. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 277. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 278. NORWAY SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 281. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 282. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 284. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 285. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 286. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. POLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY SOLID TUMORS, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY POLYMER TYPE, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC SUSTAINED RELEASE INJECTABLES MARKET SIZE, BY END USER, 2018-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Sustained Release Injectables market report include:
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Abbott Laboratories
  • Amgen Inc.
  • Baxter International Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.45 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Injectable Drug Delivery Market by Device Type, Usability, Route of Administration, Distribution Channel, Therapeutic Application, End-user - Global Forecast to 2030 - Product Image

Injectable Drug Delivery Market by Device Type, Usability, Route of Administration, Distribution Channel, Therapeutic Application, End-user - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Injectable Cytotoxic Drugs - Global Strategic Business Report - Product Image

Injectable Cytotoxic Drugs - Global Strategic Business Report

  • Report
  • 380 Pages
  • Global
From
Sterile Injectable Drugs Market by Type, Drug Class, Administration Route, Dosage Form, Therapeutic Application, Distribution Channel - Global Forecast to 2030 - Product Image

Sterile Injectable Drugs Market by Type, Drug Class, Administration Route, Dosage Form, Therapeutic Application, Distribution Channel - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Injectable Drug Delivery Devices Market - Product Image

Injectable Drug Delivery Devices Market

  • Report
  • 166 Pages
  • Global
From
Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sterile Injectables CDMO Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Product, By Service, By Therapeutic Area, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From

About the Sustained Release Injectable Market

The Sustained Release Injectable market is a subset of the Infusions and Injectables market. It is composed of drugs that are administered via injection and are designed to provide a slow and steady release of the active ingredient over a period of time. This type of drug delivery system is beneficial for patients who require a consistent level of medication over a long period of time. It also reduces the number of injections needed, which can be beneficial for patients who have difficulty with frequent injections. The Sustained Release Injectable market is composed of a variety of drugs, including hormones, antibiotics, and analgesics. These drugs are typically administered via intramuscular or subcutaneous injection, and the active ingredient is slowly released over a period of time. Some companies in the Sustained Release Injectable market include Pfizer, Merck, Novartis, and Sanofi. These companies produce a variety of drugs that are designed to provide a slow and steady release of the active ingredient over a period of time. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.